[Skip to Content]
[Skip to Content Landing]
Editor's Correspondence
January 25, 1999

Reduction of Labor Costs Associated With Treating Migraine in the Workplace

Arch Intern Med. 1999;159(2):197. doi:

We recently reported a study1 of the effects of sumatriptan succinate on workplace productivity during a migraine attack, where treatment with subcutaneous sumatriptan reduced migraine-associated productivity loss by approximately 50% compared with placebo. To examine the annual labor costs associated with the differences observed in workplace productivity losses, we have completed a post hoc cost analysis of these data.